ML Pharma SRL
3.0 FTEThe score of ML Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +183 % Total assets -6 % Headcount (avg FTE) +50 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ML Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
ML Pharma's financial analysis
- Solvency21.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ML Pharma
ML Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.627.454
- VAT number
- BE0795627454
- Peppol
- Registered · 0208:0795627454 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Jan 2023
- Registered office
- 1020 Brussels
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ML Pharma (SRL) has been based in Brussels since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 13,891 € and equity of 122,318 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 21.3%, below the median of its sector (37.8%).
Companies similar to ML Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek De Vijzel Retail sale of pharmaceutical products Zoersel · balance sheet 509,493 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- P.J. VLEUGELS et Cie Retail sale of pharmaceutical products Frameries · balance sheet 558,880 €
- Pharmacie Meurens Retail sale of pharmaceutical products Oupeye · balance sheet 539,712 €
- Biloba Kessel-LO Retail sale of pharmaceutical products Leuven · balance sheet 611,082 €
- Visa Pharma Retail sale of pharmaceutical products Chaudfontaine · balance sheet 615,498 €
- LNR Retail sale of pharmaceutical products Kasterlee · balance sheet 516,544 €
- Anglopharma Retail sale of pharmaceutical products De Panne · balance sheet 669,817 €
Frequently asked questions about ML Pharma
What is the revenue of ML Pharma?
ML Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ML Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0795627454 for ML Pharma, if the company is VAT-registered. Its company number (CBE) is 0795.627.454.
Where is the registered office of ML Pharma?
According to the CBE register, the registered office of ML Pharma is in 1020 Brussels.
What is the equity of ML Pharma?
At the close of the 2025 financial year, the equity of ML Pharma amounts to 122,318 €, a solvency of 21.3% of total assets.
How many people work at ML Pharma?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ML Pharma?
The register lists 1 active mandates at ML Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ML Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →